Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial
Internal Medicine Journal · 2023-12 · 53 (12) · 2346-2349
DOI: 10.1111/imj.16292 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Internal Medicine Journal, online erschienen am 21.12.2023. Verfasst von Marliese Alexander und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Neoplasms, Telemedicine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Peter MacCallum Cancer Centre, Peter MacCallum Cancer Foundation.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
This cost analysis, from a societal perspective, compared the cost difference of a networked teletrial model (NTTM) with four regional hubs versus conventional trial operation at a single metropolitan specialist centre. The Australian phase 3 cancer interventional randomised controlled trial included 152 of 328 regional participants (patient enrolment 2018–2021; 6‐month primary end point). The NTTM significantly reduced (AU$2155 per patient) patient travel cost and time and lost productivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
- Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.
- Deakin University, Melbourne, Victoria, Australia.
- Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
- Border Medical Oncology and Haematology Research Unit, Albury Wodonga Regional Cancer Centre, Albury Wodonga, New South Wales, Australia.
ORCID-Profile: Marliese Alexander, Ian Collins, Craig Underhill
Förderung
- National Health and Medical Research Council
- Peter MacCallum Cancer Centre
- Peter MacCallum Cancer Foundation
- Victorian Cancer Agency
- Peter MacCallum Foundation
Zitieren
APA
Alexander, M., Collins, I., Abraham, P., Underhill, C., Harris, S., Torres, J., Sharma, S., Solomon, B., Tran-Duy, A., & Burbury, K. (2023). Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial. Internal Medicine Journal, 53(12), 2346-2349. https://doi.org/10.1111/imj.16292
Vancouver
Alexander M, Collins I, Abraham P, Underhill C, Harris S, Torres J, et al. Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial. Internal Medicine Journal. 2023;53(12):2346-2349. doi:10.1111/imj.16292
BibTeX
@article{Alexander2023,
author = {Alexander, Marliese and Collins, Ian and Abraham, Patrick and Underhill, Craig and Harris, Sam and Torres, Javier and Sharma, Sharad and Solomon, Benjamin and Tran-Duy, An and Burbury, Kate},
title = {Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial},
journal = {Internal Medicine Journal},
year = {2023},
volume = {53},
number = {12},
pages = {2346--2349},
doi = {10.1111/imj.16292}
}
EUVIMED